当前位置: 首页 > 详情页

The long noncoding RNA lnc-ob1 facilitates bone formation by upregulating Osterix in osteoblasts

文献详情

资源类型:
机构: [1]Department of Oral Implantology, School of Stomatology, Tongji University, Shanghai Engineering Research Center of Tooth Restoration and Regeneration, Shanghai, China. [2]Beijing Advanced Innovation Center for Big Data-Based Precision Medicine, and School of Biological Science and Medical Engineering, Beihang University, Beijing, China. [3]Department of Cell Biology, and Institute of Biomedicine, College of Life Science and Technology, Jinan University, Guangzhou, China. [4]Key Laboratory of Functional Protein Research of Guangdong Higher Education Institutes, Institute of Life and Health Engineering, Jinan University, Guangzhou, China. [5]Institute of Pediatrics, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, Guangzhou, China. [6]The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China. [7]Institute of Sports Medicine, Beijing Key Laboratory of Sports Injuries, Peking University Third Hospital, Beijing, China. [8]Department of Neurosurgery & China-America Institute of Neuroscience, Xuanwu Hospital, Capital Medical University, Beijing, China.
出处:
ISSN:

摘要:
Long noncoding RNAs (lncRNAs) have emerged as integral regulators of physiology and disease, but specific roles of lncRNAs in bone disease remain largely unknown. Here, we show that lnc-ob1 regulates osteoblast activity and bone formation in mice by upregulating the osteogenic transcription factor Osterix. Expression of lnc-ob1 is enriched in osteoblasts and upregulated during osteoblastogenesis. We demonstrate that osteoblast-specific knock-in of lnc-ob1 enhances bone formation and increases bone mass. Pharmacological overexpression of lnc-ob1 specifically in osteoblasts confers resistance to ovariectomy-induced osteoporosis in mice. In humans, expression of the homologue, lnc-OB1, decreases with age in osteoblasts of patients with osteoporosis. Mechanistically, lnc-ob1 upregulates the expression of Osterix in mouse and human osteoblasts, probably via inhibition of H3K27me3 methylation. Our data indicate that lnc-OB1 regulates bone formation and might be a drug target for the treatment of osteoporosis. © 2019, The Author(s), under exclusive licence to Springer Nature Limited.

语种:
中科院(CAS)分区:
出版当年[2018]版:
最新[2023]版:
大类 | 1 区 医学
小类 | 1 区 内分泌学与代谢
第一作者:
第一作者机构: [1]Department of Oral Implantology, School of Stomatology, Tongji University, Shanghai Engineering Research Center of Tooth Restoration and Regeneration, Shanghai, China.
共同第一作者:
通讯作者:
通讯机构: [1]Department of Oral Implantology, School of Stomatology, Tongji University, Shanghai Engineering Research Center of Tooth Restoration and Regeneration, Shanghai, China. [2]Beijing Advanced Innovation Center for Big Data-Based Precision Medicine, and School of Biological Science and Medical Engineering, Beihang University, Beijing, China. [3]Department of Cell Biology, and Institute of Biomedicine, College of Life Science and Technology, Jinan University, Guangzhou, China. [4]Key Laboratory of Functional Protein Research of Guangdong Higher Education Institutes, Institute of Life and Health Engineering, Jinan University, Guangzhou, China. [6]The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16409 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院